TY - JOUR
BT - The Lancet Neurology
PY - 2018
SP - 1053 
EP -  1060
T2 - The Lancet Neurology
TI - Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
VL - 17
ER -